New hope for Tough-to-Treat blood cancer: phase 3 trial tests experimental pill
Disease control
Recruiting now
This study is testing whether an experimental pill called XNW5004 works better than an existing drug (Chidamide) for patients whose peripheral T-cell lymphoma has come back or hasn't responded to prior treatment. It's a Phase 3 trial enrolling 120 adults who have already tried at…
Phase: PHASE3 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC